Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301

NCT02954458 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT02954458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02954458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
January 9, 2017
Completion date
November 5, 2020
Enrollment
61 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

short bowel syndrome